Educated Patient® Breast Cancer Summit

Expert Talks the Who, What and When of Breast Cancer Genetic Testing

November 24th 2021, 8:00pm


By understanding family history, an individual can better reveal their genetic breast cancer risk and whether or not they are a candidate for genetic testing.

Understanding Radiation Therapy as a Patient with Breast Cancer

November 23rd 2021, 8:00pm


Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid.

Unpacking the Current Treatment Options for Metastatic Breast Cancer

November 17th 2021, 8:00pm


An expert explains what treatment strategies are available for patients with metastatic breast cancer, how far research has come and why patients shouldn’t lose hope.

How to Prepare for Breast Cancer Surgery: Know What Questions to Ask

November 16th 2021, 4:00pm


A breast surgeon discusses what patients and their caregivers should know before breast cancer surgery.

The Complexity of Decision-Making for Early-Stage Breast Cancer Treatment

November 15th 2021, 8:00pm


Navigating discussions around treatments for early-stage breast cancer may be difficult, but feeling comfortable with one’s cancer team and knowing about all the available options may help.

Highlights From CURE®'s Educated Patient® Breast Cancer Summit

April 8th 2021, 1:00pm


If you missed any part of CURE®’s Educated Patient® Breast Cancer Summit, take a look at this roundup of stories that highlight the expert insight and guidance that was shared throughout the day.

Diet and Exercise Can Play an Important Role in Breast Cancer Survivors

March 17th 2021, 1:00pm


Increasing healthy eating habits and exercise is important in patients with breast cancer, according to an expert from Mass General Cancer Center.

Emerging Therapies Show Promise in Treating Metastatic Breast Cancer

March 16th 2021, 1:00pm


An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.

‘The Future is Brighter’ for Triple-Negative Breast Cancer

March 11th 2021, 7:00pm


Triple-negative breast cancer, which is found in 15%-20% of invasive breast cancers, is a challenge when it comes to treatment, but thanks to new drug approvals and therapy regimens, the treatment landscape has progressed in recent years, according to an expert.

How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape

March 11th 2021, 2:00pm


Targeted therapies that attack cancer in a more precise way than traditional chemotherapy are being used more often in the field of breast cancer, but the solution in utilizing them lies within the patient-oncologist relationship, according to an expert from the Massachusetts General Hospital Cancer Center.